These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31661236)

  • 21. A NIR light-triggered drug delivery system using core-shell gold nanostars-mesoporous silica nanoparticles based on multiphoton absorption photo-dissociation of 2-nitrobenzyl PEG.
    Hernández-Montoto A; Gorbe M; Llopis-Lorente A; Terrés JM; Montes R; Cao-Milán R; Díaz de Greñu B; Alfonso M; Orzaez M; Marcos MD; Martínez-Máñez R; Sancenón F
    Chem Commun (Camb); 2019 Aug; 55(61):9039-9042. PubMed ID: 31292589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sugar and pH dual-responsive snap-top nanocarriers based on mesoporous silica-coated Fe3O4 magnetic nanoparticles for cargo delivery.
    Qiu XL; Li QL; Zhou Y; Jin XY; Qi AD; Yang YW
    Chem Commun (Camb); 2015 Mar; 51(20):4237-40. PubMed ID: 25670321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
    van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
    ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
    Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
    J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
    de la Torre C; Mondragón L; Coll C; Sancenón F; Marcos MD; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M
    Chemistry; 2014 Nov; 20(47):15309-14. PubMed ID: 25303093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic silica nanotubes: synthesis, drug release, and feasibility for magnetic hyperthermia.
    Chen X; Klingeler R; Kath M; El Gendy AA; Cendrowski K; Kalenczuk RJ; Borowiak-Palen E
    ACS Appl Mater Interfaces; 2012 Apr; 4(4):2303-9. PubMed ID: 22486255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia.
    Tao C; Zhu Y
    Dalton Trans; 2014 Nov; 43(41):15482-90. PubMed ID: 25190592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
    Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
    Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells.
    Liu HM; Wu SH; Lu CW; Yao M; Hsiao JK; Hung Y; Lin YS; Mou CY; Yang CS; Huang DM; Chen YC
    Small; 2008 May; 4(5):619-26. PubMed ID: 18491363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silica composite nanoparticles containing fluorescent solid core and mesoporous shell with different thickness as drug carrier.
    Ran Z; Sun Y; Chang B; Ren Q; Yang W
    J Colloid Interface Sci; 2013 Nov; 410():94-101. PubMed ID: 24011559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of mesoporous silica particles as drug carriers in hydrogels.
    Lunter DJ
    Pharm Dev Technol; 2018 Oct; 23(8):826-831. PubMed ID: 28826298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smart drug delivery through DNA/magnetic nanoparticle gates.
    Ruiz-Hernández E; Baeza A; Vallet-Regí M
    ACS Nano; 2011 Feb; 5(2):1259-66. PubMed ID: 21250653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
    J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-propelled Janus mesoporous silica nanomotors with sub-100 nm diameters for drug encapsulation and delivery.
    Xuan M; Shao J; Lin X; Dai L; He Q
    Chemphyschem; 2014 Aug; 15(11):2255-60. PubMed ID: 24740913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facile synthesis of yolk-shell magnetic mesoporous carbon microspheres for efficient enrichment of low abundance peptides.
    Wan H; Qin H; Xiong Z; Zhang W; Zou H
    Nanoscale; 2013 Nov; 5(22):10936-44. PubMed ID: 24061763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
    Xu W; Ge P; Niu B; Zhang X; Liu J; Xie J
    J Colloid Interface Sci; 2018 Oct; 527():141-150. PubMed ID: 29787950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.